1ZS0 - Header Asymmetric Unit

HEADER HYDROLASE 23-MAY-05 1ZS0

TITLE CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN MMP-8 AND A TITLE 2 PHOSPHONATE INHIBITOR (S-ENANTIOMER)

COMPND MOL_ID: 1; COMPND 2 MOLECULE: NEUTROPHIL COLLAGENASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: CATALYTIC DOMAIN OF NEUTROPHIL COLLAGENASE COMPND 5 (RESIDUES:80-242); COMPND 6 SYNONYM: MATRIX METALLOPROTEINASE-8, MMP-8, PMNL COMPND 7 COLLAGENASE, PMNL-CL; COMPND 8 EC: 3.4.24.34; COMPND 9 ENGINEERED: YES

SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MMP8, CLG1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PSVB30

KEYWDS PHOSPHONIC INHIBITOR, SULPHONAMIDE JUNCTION, KEYWDS 2 STEREOSELECTIVE INHIBITION, HYDROLASE

EXPDTA X-RAY DIFFRACTION

AUTHOR G.POCHETTI,E.GAVUZZO,C.CAMPESTRE,M.AGAMENNONE,P.TORTORELLA, AUTHOR 2 V.CONSALVI,C.GALLINA,O.HILLER,H.TSCHESCHE,P.A.TUCKER,F.MAZZA

REVDAT 2 24-FEB-09 1ZS0 1 VERSN REVDAT 1 02-MAY-06 1ZS0 0

JRNL AUTH G.POCHETTI,E.GAVUZZO,C.CAMPESTRE,M.AGAMENNONE, JRNL AUTH 2 P.TORTORELLA,V.CONSALVI,C.GALLINA,O.HILLER, JRNL AUTH 3 H.TSCHESCHE,P.A.TUCKER,F.MAZZA JRNL TITL STRUCTURAL INSIGHT INTO THE STEREOSELECTIVE JRNL TITL 2 INHIBITION OF MMP-8 BY ENANTIOMERIC SULFONAMIDE JRNL TITL 3 PHOSPHONATES. JRNL REF J.MED.CHEM. V. 49 923 2006 JRNL REFN ISSN 0022-2623 JRNL PMID 16451058 JRNL DOI 10.1021/JM050787+

REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH A.G.PAVLOVSKY,M.G.WILLIAMS,Q.Z.YE,D.F.ORTWINE, REMARK 1 AUTH 2 C.F.PURCHASE 2ND,A.D.WHITE,V.DHANARAJ,B.D.ROTH, REMARK 1 AUTH 3 L.L.JOHNSON,D.HUPE,C.HUMBLET,T.L.BLUNDELL REMARK 1 TITL X-RAY STRUCTURE OF HUMAN STROMELYSIN CATALYTIC REMARK 1 TITL 2 DOMAIN COMPLEXED WITH NONPEPTIDE INHIBITORS: REMARK 1 TITL 3 IMPLICATIONS FOR INHIBITOR SELECTIVITY REMARK 1 REF PROTEIN SCI. V. 8 1455 1999 REMARK 1 REFN ISSN 0961-8368 REMARK 1 PMID 10422833 REMARK 1 REFERENCE 2 REMARK 1 AUTH E.GAVUZZO,G.POCHETTI,F.MAZZA,C.GALLINA,B.GORINI, REMARK 1 AUTH 2 S.D'ALESSIO,M.PIEPER,H.TSCHESCHE,P.A.TUCKER REMARK 1 TITL TWO CRYSTAL STRUCTURES OF HUMAN NEUTROPHIL REMARK 1 TITL 2 COLLAGENASE, ONE COMPLEXED WITH A PRIMED- AND THE REMARK 1 TITL 3 OTHER WITH AN UNPRIMED-SIDE INHIBITOR: REMARK 1 TITL 4 IMPLICATIONS FOR DRUG DESIGN REMARK 1 REF J.MED.CHEM. V. 43 3377 2000 REMARK 1 REFN ISSN 0022-2623 REMARK 1 PMID 10978185 REMARK 1 DOI 10.1021/JM9909589 REMARK 1 REFERENCE 3 REMARK 1 AUTH F.GRAMS,P.REINEMER,J.C.POWERS,T.KLEINE,M.PIEPER, REMARK 1 AUTH 2 H.TSCHESCHE,R.HUBER,W.BODE REMARK 1 TITL X-RAY STRUCTURES OF HUMAN NEUTROPHIL COLLAGENASE REMARK 1 TITL 2 COMPLEXED WITH PEPTIDE HYDROXAMATE AND PEPTIDE REMARK 1 TITL 3 THIOL INHIBITORS. IMPLICATIONS FOR SUBSTRATE REMARK 1 TITL 4 BINDING AND RATIONAL DRUG DESIGN. REMARK 1 REF EUR.J.BIOCHEM. V. 228 830 1995 REMARK 1 REFN ISSN 0014-2956 REMARK 1 PMID 7737183 REMARK 1 DOI 10.1111/J.1432-1033.1995.TB20329.X

REMARK 2 REMARK 2 RESOLUTION. 1.56 ANGSTROMS.

REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.56 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 10.0 REMARK 3 NUMBER OF REFLECTIONS : 19432 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.210 REMARK 3 FREE R VALUE : 0.235 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 2146 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1282 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 42 REMARK 3 SOLVENT ATOMS : 244 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 14.10 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.34 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL

REMARK 4 REMARK 4 1ZS0 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08

REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 01-JUN-05. REMARK 100 THE RCSB ID CODE IS RCSB033050.

REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 28-JAN-04 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : EMBL/DESY, HAMBURG REMARK 200 BEAMLINE : X13 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.8042 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MAR REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21073 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.560 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.8 REMARK 200 DATA REDUNDANCY : 5.500 REMARK 200 R MERGE (I) : 0.04500 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 20.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.56 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.62 REMARK 200 COMPLETENESS FOR SHELL (%) : 90.1 REMARK 200 DATA REDUNDANCY IN SHELL : 5.00 REMARK 200 R MERGE FOR SHELL (I) : 0.17100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 9.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1I76 REMARK 200 REMARK 200 REMARK: NULL

REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 38.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.00 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG6000, MES/NAOH, NACL, CACL2, REMARK 280 ZNCL2, NA PHOSPHATE, PH 6.0, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 293.0K

REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 16.03100 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 35.25850 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 33.94200 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 35.25850 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 16.03100 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 33.94200 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL

REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.

REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000

REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 1026 O HOH A 1144 2.15 REMARK 500 O HOH A 1003 O HOH A 1129 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 1001 O HOH A 1161 3555 2.06 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 145 -128.22 41.00 REMARK 500 ASN A 157 -162.47 55.81 REMARK 500 REMARK 500 REMARK: NULL

REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A1152 DISTANCE = 5.06 ANGSTROMS REMARK 525 HOH A1177 DISTANCE = 7.28 ANGSTROMS REMARK 525 HOH A1214 DISTANCE = 5.16 ANGSTROMS

REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 999 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 EIN A 994 O6 REMARK 620 2 HIS A 207 NE2 100.8 REMARK 620 3 HIS A 197 NE2 108.6 118.1 REMARK 620 4 HIS A 201 NE2 127.4 99.3 103.4 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 996 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HOH A1126 O REMARK 620 2 HOH A1127 O 84.6 REMARK 620 3 ASP A 173 OD1 101.0 167.2 REMARK 620 4 GLY A 171 O 165.1 81.2 93.8 REMARK 620 5 GLY A 169 O 70.5 91.6 101.1 105.2 REMARK 620 6 ASP A 137 O 89.3 80.9 87.7 92.9 159.1 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 997 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ILE A 159 O REMARK 620 2 ASP A 177 OD2 89.3 REMARK 620 3 GLY A 155 O 173.2 87.2 REMARK 620 4 ASN A 157 O 98.7 168.6 84.0 REMARK 620 5 ASP A 154 OD1 86.3 86.0 87.7 86.4 REMARK 620 6 GLU A 180 OE2 88.3 102.6 98.1 85.9 169.8 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 998 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 149 OD2 REMARK 620 2 HIS A 175 ND1 94.0 REMARK 620 3 HIS A 147 NE2 109.1 108.2 REMARK 620 4 HIS A 162 NE2 116.0 113.4 114.2 REMARK 620 N 1 2 3

REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA A 996 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA A 997 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 998 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 999 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EIN A 994 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MES A 995

DBREF 1ZS0 A 80 242 UNP P22894 MMP8_HUMAN 100 262

SEQRES 1 A 163 MET LEU THR PRO GLY ASN PRO LYS TRP GLU ARG THR ASN SEQRES 2 A 163 LEU THR TYR ARG ILE ARG ASN TYR THR PRO GLN LEU SER SEQRES 3 A 163 GLU ALA GLU VAL GLU ARG ALA ILE LYS ASP ALA PHE GLU SEQRES 4 A 163 LEU TRP SER VAL ALA SER PRO LEU ILE PHE THR ARG ILE SEQRES 5 A 163 SER GLN GLY GLU ALA ASP ILE ASN ILE ALA PHE TYR GLN SEQRES 6 A 163 ARG ASP HIS GLY ASP ASN SER PRO PHE ASP GLY PRO ASN SEQRES 7 A 163 GLY ILE LEU ALA HIS ALA PHE GLN PRO GLY GLN GLY ILE SEQRES 8 A 163 GLY GLY ASP ALA HIS PHE ASP ALA GLU GLU THR TRP THR SEQRES 9 A 163 ASN THR SER ALA ASN TYR ASN LEU PHE LEU VAL ALA ALA SEQRES 10 A 163 HIS GLU PHE GLY HIS SER LEU GLY LEU ALA HIS SER SER SEQRES 11 A 163 ASP PRO GLY ALA LEU MET TYR PRO ASN TYR ALA PHE ARG SEQRES 12 A 163 GLU THR SER ASN TYR SER LEU PRO GLN ASP ASP ILE ASP SEQRES 13 A 163 GLY ILE GLN ALA ILE TYR GLY

HET CA A 996 1 HET CA A 997 1 HET ZN A 998 1 HET ZN A 999 1 HET EIN A 994 26 HET MES A 995 12

HETNAM CA CALCIUM ION HETNAM ZN ZINC ION HETNAM EIN (1S)-1-{[(4'-METHOXY-1,1'-BIPHENYL-4-YL) HETNAM 2 EIN SULFONYL]AMINO}-2-METHYLPROPYLPHOSPHONIC ACID HETNAM MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID

FORMUL 2 CA 2(CA 2+) FORMUL 4 ZN 2(ZN 2+) FORMUL 6 EIN C17 H22 N O6 P S FORMUL 7 MES C6 H13 N O4 S FORMUL 8 HOH *244(H2 O)

HELIX 1 1 SER A 105 VAL A 122 1 18 HELIX 2 2 ASN A 190 LEU A 203 1 14 HELIX 3 3 PRO A 230 GLY A 242 1 13

SHEET 1 A 5 ILE A 127 ARG A 130 0 SHEET 2 A 5 ASN A 92 ILE A 97 1 N LEU A 93 O ILE A 127 SHEET 3 A 5 ILE A 138 TYR A 143 1 O ILE A 140 N ARG A 96 SHEET 4 A 5 ALA A 174 ASP A 177 1 O ALA A 174 N ASN A 139 SHEET 5 A 5 ALA A 161 ALA A 163 -1 N HIS A 162 O HIS A 175

LINK O6 EIN A 994 ZN ZN A 999 1555 1555 1.92 LINK CA CA A 996 O HOH A1126 1555 1555 2.62 LINK CA CA A 996 O HOH A1127 1555 1555 2.64 LINK CA CA A 996 OD1 ASP A 173 1555 1555 2.53 LINK CA CA A 996 O GLY A 171 1555 1555 2.51 LINK CA CA A 996 O GLY A 169 1555 1555 2.63 LINK CA CA A 996 O ASP A 137 1555 1555 2.46 LINK CA CA A 997 O ILE A 159 1555 1555 2.43 LINK CA CA A 997 OD2 ASP A 177 1555 1555 2.50 LINK CA CA A 997 O GLY A 155 1555 1555 2.34 LINK CA CA A 997 O ASN A 157 1555 1555 2.44 LINK CA CA A 997 OD1 ASP A 154 1555 1555 2.45 LINK CA CA A 997 OE2 GLU A 180 1555 1555 2.32 LINK ZN ZN A 998 OD2 ASP A 149 1555 1555 2.01 LINK ZN ZN A 998 ND1 HIS A 175 1555 1555 2.13 LINK ZN ZN A 998 NE2 HIS A 147 1555 1555 2.09 LINK ZN ZN A 998 NE2 HIS A 162 1555 1555 2.05 LINK ZN ZN A 999 NE2 HIS A 207 1555 1555 2.16 LINK ZN ZN A 999 NE2 HIS A 197 1555 1555 2.08 LINK ZN ZN A 999 NE2 HIS A 201 1555 1555 2.10

CISPEP 1 ASN A 188 TYR A 189 0 0.43

SITE 1 AC1 6 ASP A 137 GLY A 169 GLY A 171 ASP A 173 SITE 2 AC1 6 HOH A1126 HOH A1127 SITE 1 AC2 6 ASP A 154 GLY A 155 ASN A 157 ILE A 159 SITE 2 AC2 6 ASP A 177 GLU A 180 SITE 1 AC3 4 HIS A 147 ASP A 149 HIS A 162 HIS A 175 SITE 1 AC4 4 HIS A 197 HIS A 201 HIS A 207 EIN A 994 SITE 1 AC5 21 THR A 129 GLY A 158 ILE A 159 LEU A 160 SITE 2 AC5 21 ALA A 161 HIS A 162 LEU A 193 HIS A 197 SITE 3 AC5 21 GLU A 198 HIS A 201 HIS A 207 LEU A 214 SITE 4 AC5 21 TYR A 216 PRO A 217 ASN A 218 TYR A 219 SITE 5 AC5 21 ZN A 999 HOH A1040 HOH A1070 HOH A1102 SITE 6 AC5 21 HOH A1148 SITE 1 AC6 15 ALA A 112 ASP A 115 SER A 186 PHE A 192 SITE 2 AC6 15 THR A 224 SER A 225 TYR A 227 HOH A1002 SITE 3 AC6 15 HOH A1016 HOH A1096 HOH A1121 HOH A1129 SITE 4 AC6 15 HOH A1132 HOH A1134 HOH A1183

CRYST1 32.062 67.884 70.517 90.00 90.00 90.00 P 21 21 21 4

ORIGX1 1.000000 0.000000 0.000000 0.00000

ORIGX2 0.000000 1.000000 0.000000 0.00000

ORIGX3 0.000000 0.000000 1.000000 0.00000

SCALE1 0.031190 0.000000 0.000000 0.00000

SCALE2 0.000000 0.014731 0.000000 0.00000

SCALE3 0.000000 0.000000 0.014181 0.00000